abstract |
The present application describes compounds according to Formula I, wherein R 1 , R 2 , R 3 , R 4 , X and Y are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. |